000388 A PHASE I/II STUDY OF THE TRIPLET OF ORAL TOPOTE-CAN, CARBOPLATIN AND PACLITAXEL GIVEN IN A "REVERSE SCHEDULE" IN PATIENTS WITH OVARIAN CANCER. (1st September 2005)